Skip to main navigation
Skip to search
Skip to main content
Amsterdam UMC Home
Help & FAQ
Link opens in a new tab
Search content at Amsterdam UMC
Home
Researchers
Departments & Research Institutes
Projects & Funding
Publications
Datasets
Prizes
Activities
Courses
Cohorts
Press/Media
Impact
NVZA award best original research
Crul, Mirjam
(Recipient)
Pharmacy and Clinical Pharmacology
Affiliatie VU
CCA - Cancer Treatment and quality of life
Cancer Center Amsterdam
Prize
›
Academic
Description
best original research publication "Randomized phase I clinical and
pharmacologic study of weekly versus twice-weekly dose-intensive cisplatin and
gemcitabine in patients with advanced non-small cell lung cancer"
Awarded date
2004
Degree of recognition
National
Granting Organisations
NVZA
Fingerprint
Twice Daily
100%
Cisplatin
100%
Locally Advanced Non-small Cell Lung Cancer (LA-NSCLC)
100%
Dose-intensive
100%
Non Small Cell Lung Cancer
100%
X